The United States is the most expensive healthcare market in the world. For international programs with any U.S. exposure, this is the primary driver of loss ratio performance. A single complex inpatient admission at a hospital with no contracted relationship can generate a bill in the $200,000–$800,000 range — with no obligation to relate to actual cost of care.
Most programs respond with retrospective tactics: bill review, UCR negotiation, case-by-case settlement. These tools have value, but the most powerful cost containment lever is upstream — influencing where care is sought before the admission occurs.
Why U.S. Billed Charges Are the Wrong Starting Point
U.S. hospitals publish a "chargemaster" — retail prices for every service and procedure. These prices are not evidence-based and not related to what Medicare or large insurers actually pay. For patients or programs without contracted network access, chargemaster is what gets billed. The contrast with networked rates is stark: for the same admission, the network version and out-of-network version can differ by hundreds of thousands of dollars. Network access is not a feature of U.S. cost containment. It is the foundation.
Upstream Lever 1: Pre-Admission Network Steering
The most effective action is steering covered members toward in-network providers before they receive care. This requires: active case management from the moment a member contacts the assistance line, a real-time network database identifying in-network providers by location and specialty, and case managers trained to guide members toward appropriate options without denying legitimate care.
Upstream Lever 2: Guarantee of Payment Negotiation
When a member is admitted to a U.S. hospital, a TPA notified at Day 1 can engage the hospital's business office before the bill is generated. Rates can be negotiated prospectively based on anticipated DRG and length of stay. A prospective rate agreement is almost always better than retrospective negotiation after a large bill has been anchored by the hospital's billing department.
Upstream Lever 3: Managed Length of Stay
Each additional inpatient day adds facility fees, professional fees, and ancillary charges. Medically unnecessary length of stay is one of the most significant drivers of excess U.S. medical cost. Managed length of stay requires concurrent review — a clinical reviewer engaging with the treating team during the admission, assessing medical necessity for each additional day, and identifying the earliest clinically appropriate discharge date.
Upstream Lever 4: Site of Care Optimization
Not every situation requires an acute care hospital inpatient admission. An MRI at an outpatient imaging center costs a fraction of the same MRI ordered as a hospital outpatient service. An elective procedure at an ambulatory surgical center costs substantially less than the same procedure at a hospital OR. Building site-of-care guidance into the care management model reduces cost without reducing access.
The Retrospective Layer Still Matters
Upstream tools don't eliminate the need for retrospective containment — true emergencies will go to the nearest facility regardless. Bill review and UCR negotiation on those cases is essential. The point is that the largest savings are made before the bill is generated. Retrospective tools operate in a fundamentally worse position than upstream intervention.